Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer

Cervical cancer (CaCx) is the fourth most prevalent cancer in women contributing to 341,831 annual deaths globally in 2020. Owing to its high mortality rate, the identification of novel inhibitors preventing CaCx progression is of utmost importance. Recent studies have emphasized the use of phytoche...

Full description

Saved in:
Bibliographic Details
Main Authors: Tanya Tripathi, Apoorva Chaudhary, Divya Janjua, Udit Joshi, Nikita Aggarwal, Chetkar Chandra Keshavam, Alok Chandra Bharti
Format: Article
Language:English
Published: Open Exploration 2024-09-01
Series:Exploration of Drug Science
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A100863/100863.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199595687247872
author Tanya Tripathi
Apoorva Chaudhary
Divya Janjua
Udit Joshi
Nikita Aggarwal
Chetkar Chandra Keshavam
Alok Chandra Bharti
author_facet Tanya Tripathi
Apoorva Chaudhary
Divya Janjua
Udit Joshi
Nikita Aggarwal
Chetkar Chandra Keshavam
Alok Chandra Bharti
author_sort Tanya Tripathi
collection DOAJ
description Cervical cancer (CaCx) is the fourth most prevalent cancer in women contributing to 341,831 annual deaths globally in 2020. Owing to its high mortality rate, the identification of novel inhibitors preventing CaCx progression is of utmost importance. Recent studies have emphasized the use of phytochemicals for cancer prevention due to their low toxicity. Psoralidin, a bioactive compound extracted from the seeds of the medicinal plant Psoralea corylifolia, showcases the potential for promoting health benefits. A range of studies showing anti-inflammatory, anti-oxidant, estrogenic, neuroprotective, anti-diabetic, anti-depressant, antimicrobial, and anti-tumor activities substantiate its promising biological effects. The anti-tumor potential of psoralidin has been well-documented. Its capacity to effectively target cancer stem cells (CSCs) in general adds to its therapeutic potential. Psoralidin carries out its anti-cancer activity by inducing oxidative stress, autophagy, and apoptosis. This unique characteristic suggests its potential to be used as an adjunct molecule in combination with existing treatment to enhance the efficacy of chemo/radiotherapy for treating CaCx. However, low bioavailability and intestinal efflux limit the use of psoralidin in clinical applications. Therefore, further investigation is needed in area of drug delivery and mechanism of action to fully harness the beneficial effects of psoralidin. The present study examines the current understanding of the molecular properties of this coumestan, as well as its various molecular targets with a particular emphasis on its anti-cancer activity. The study will help in designing effective and novel therapeutic interventions for targeting signaling pathways and other regulators involved in mediating CaCx progression, which will eventually help in effective management of CaCx.
format Article
id doaj-art-ac493e0e31d74adc833994fcfd490351
institution Kabale University
issn 2836-7677
language English
publishDate 2024-09-01
publisher Open Exploration
record_format Article
series Exploration of Drug Science
spelling doaj-art-ac493e0e31d74adc833994fcfd4903512025-02-08T03:29:23ZengOpen ExplorationExploration of Drug Science2836-76772024-09-012558361310.37349/eds.2024.00063Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancerTanya Tripathi0Apoorva Chaudhary1Divya Janjua2Udit Joshi3Nikita Aggarwal4Chetkar Chandra Keshavam5Alok Chandra Bharti6https://orcid.org/0000-0002-5996-2832Molecular Oncology Laboratory, Department of Zoology, University of Delhi (North Campus), Delhi 110007, IndiaMolecular Oncology Laboratory, Department of Zoology, University of Delhi (North Campus), Delhi 110007, IndiaMolecular Oncology Laboratory, Department of Zoology, University of Delhi (North Campus), Delhi 110007, IndiaMolecular Oncology Laboratory, Department of Zoology, University of Delhi (North Campus), Delhi 110007, IndiaMolecular Oncology Laboratory, Department of Zoology, University of Delhi (North Campus), Delhi 110007, IndiaMolecular Oncology Laboratory, Department of Zoology, University of Delhi (North Campus), Delhi 110007, IndiaMolecular Oncology Laboratory, Department of Zoology, University of Delhi (North Campus), Delhi 110007, IndiaCervical cancer (CaCx) is the fourth most prevalent cancer in women contributing to 341,831 annual deaths globally in 2020. Owing to its high mortality rate, the identification of novel inhibitors preventing CaCx progression is of utmost importance. Recent studies have emphasized the use of phytochemicals for cancer prevention due to their low toxicity. Psoralidin, a bioactive compound extracted from the seeds of the medicinal plant Psoralea corylifolia, showcases the potential for promoting health benefits. A range of studies showing anti-inflammatory, anti-oxidant, estrogenic, neuroprotective, anti-diabetic, anti-depressant, antimicrobial, and anti-tumor activities substantiate its promising biological effects. The anti-tumor potential of psoralidin has been well-documented. Its capacity to effectively target cancer stem cells (CSCs) in general adds to its therapeutic potential. Psoralidin carries out its anti-cancer activity by inducing oxidative stress, autophagy, and apoptosis. This unique characteristic suggests its potential to be used as an adjunct molecule in combination with existing treatment to enhance the efficacy of chemo/radiotherapy for treating CaCx. However, low bioavailability and intestinal efflux limit the use of psoralidin in clinical applications. Therefore, further investigation is needed in area of drug delivery and mechanism of action to fully harness the beneficial effects of psoralidin. The present study examines the current understanding of the molecular properties of this coumestan, as well as its various molecular targets with a particular emphasis on its anti-cancer activity. The study will help in designing effective and novel therapeutic interventions for targeting signaling pathways and other regulators involved in mediating CaCx progression, which will eventually help in effective management of CaCx.https://www.explorationpub.com/uploads/Article/A100863/100863.pdfcervical cancerpsoralidinreactive oxygen speciesanti-inflammatoryosteoporosisanti-tumor
spellingShingle Tanya Tripathi
Apoorva Chaudhary
Divya Janjua
Udit Joshi
Nikita Aggarwal
Chetkar Chandra Keshavam
Alok Chandra Bharti
Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
Exploration of Drug Science
cervical cancer
psoralidin
reactive oxygen species
anti-inflammatory
osteoporosis
anti-tumor
title Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
title_full Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
title_fullStr Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
title_full_unstemmed Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
title_short Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
title_sort psoralidin emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
topic cervical cancer
psoralidin
reactive oxygen species
anti-inflammatory
osteoporosis
anti-tumor
url https://www.explorationpub.com/uploads/Article/A100863/100863.pdf
work_keys_str_mv AT tanyatripathi psoralidinemergingbiologicalactivitiesoftherapeuticbenefitsanditspotentialutilityincervicalcancer
AT apoorvachaudhary psoralidinemergingbiologicalactivitiesoftherapeuticbenefitsanditspotentialutilityincervicalcancer
AT divyajanjua psoralidinemergingbiologicalactivitiesoftherapeuticbenefitsanditspotentialutilityincervicalcancer
AT uditjoshi psoralidinemergingbiologicalactivitiesoftherapeuticbenefitsanditspotentialutilityincervicalcancer
AT nikitaaggarwal psoralidinemergingbiologicalactivitiesoftherapeuticbenefitsanditspotentialutilityincervicalcancer
AT chetkarchandrakeshavam psoralidinemergingbiologicalactivitiesoftherapeuticbenefitsanditspotentialutilityincervicalcancer
AT alokchandrabharti psoralidinemergingbiologicalactivitiesoftherapeuticbenefitsanditspotentialutilityincervicalcancer